ArticleDermatology and therapy2026

Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.